Introduction
The transcriptional regulatory proteins encoded by the myc proto-oncogene family have been linked to multiple aspects of eukaryotic cell function, including cell cycle progression, dierentiation, and apoptosis. Clinical and biological observations support the implications of these transcription factors in a wide range of neoplasias. c-Myc and N-Myc are involved in Burkitt lymphoma, neuroblastoma and small cell lung carcinoma. The chromosomal alterations observed in these malignancies result in degradation of myc expression, which is normally under tight transcriptional and post-transcriptional control (reviewed in Amati and Land, 1994; Hesketh, 1997) . Myc proteins are expressed in proliferating cells and are downregulated upon cell-cycle withdrawal or dierentiation.
Myc proteins hold a tripartite conserved motif, called basic-Helix ± Loop ± Helix Leucine Zipper (bHLHZip). This motif is the hallmark of a class of transcription factors which includes the USFs (Gregor et al., 1990; Sirito et al., 1992 Sirito et al., , 1994 , the TFEs (Beckmann et al., 1990; Fisher et al., 1991; Hodgkinson, 1993; Zhao et al., 1993) , Max (Blackwood and Eisenman, 1991; Prendergast et al., 1991) , and the Mads (Ayer et al., 1993; Hurlin et al., 1995b; Zervos et al., 1993) .
The basic region recognizes a canonical CANNTG DNA-binding sequence called E-box (Blackwell et al., 1993) . The HLH and Zip motifs participate in protein dimerization, a prerequisite for DNA-binding. Max is a widely expressed and stable bHLHZip protein that forms DNA-binding heterodimers with the Myc and Mad proteins (Ayer et al., 1993; Blackwood and Eisenman, 1991; Hurlin et al., 1995b; Prendergast et al., 1991; Zervos et al., 1993) . Although Myc-Max and Mad-Max heterodimers bind the same E-box-related DNA sequences, they elicit dierent transcriptional responses. Reporter genes under the control of E-box elements are activated by Myc-Max, while Mad-Max represses their transcription (Amati et al., 1992; Ayer et al., 1993; Hurlin et al., 1995b; Kretzner et al., 1992) . Thus it appears that Myc activates, while Mad represses, genes involved in promoting cellular proliferation (reviewed in Cole and McMahon, 1999; Dang, 1999; Peters and Taparowsky, 1998) .
Recently, two mammalian Mad interactors, mSin3A and mSin3B, homologous to the Saccharomyces cerevisiae transcriptional corepressor Sin3p, were identi®ed (Ayer et al., 1995; Schreiber Agus et al., 1995) . They are required in Mad-mediated transcriptional repression (Kasten et al., 1996; Roussel et al., 1996) . Sin3p represses a wide spectrum of genes when fused to a heterologous DNA binding domain. Several lines of evidence suggest that it may function by inhibiting the general transcription machinery, either by direct interaction or through a negatively acting chromatin structure. Its genetical partner, Rpd3p, was shown to exert histone deacetylase activity, suggesting that repression occurs by modi®cation of histones and hence stabilization of chromatin structure (Kasten et al., 1997; Taunton et al., 1996) . Similarly, mSIN3A and mSIN3B are part of high molecular weight protein complexes which contain the mammalian histone deacetylases (Alland et al., 1997; Hassig et al., 1997; Heinzel et al., 1997; Laherty et al., 1997; Nagy et al., 1997; Zhang et al., 1997b) .
We and others isolated a new member of the Myc/ Max/Mad bHLHZip family when searching for transcribed sequences of human chromosome 17p13.3. This protein, named Rox (Mnt), heterodimerizes with Max and binds a non-canonical E-box. Rox is able to repress transcription, although in HeLa cells it behaves as an activator. Rox holds a SIN3 interaction domain (SID) and binds the PAH2 regions of both mSIN3A and yeast SIN3p (Hurlin et al., 1997; Meroni et al., 1997) . Rox steady state mRNA is only present in WI-38 quiescent cells, suggesting that Rox might negatively regulate the entry into the cell cycle by repressing genes that should be upregulated to overcome the restriction point. Rox might therefore be considered a Myc antagonist.
In this paper, we describe the isolation of Mlx, a bHLHZip protein, in a screen for new Rox interactors. The same gene was independently identi®ed in a screen for Mad1 interacting proteins (Billin et al., 1999) . We demonstrate that Mlx is interacting in vitro and in vivo with Rox. Moreover, contrary to previous reports, we show that Mlx is able to homodimerize and to bind Ebox sequences at low concentration levels. Our results and previous reports (Billin et al., 1999) suggest that Mlx cooperates with Mad1, Mad4, Rox and possibly other bHLHZip proteins in a novel regulatory pathway parallel to the Max transcription factor controlled network.
Results

Identification of a new bHLHZip protein
To identify new proteins that interact with Rox we performed a yeast two-hybrid assay using a HeLa cDNA library Zervos et al., 1993) . A fusion between LexA and Rox residues 60 ± 582 was used as bait. This construct lacks the ®rst 59 amino acids of Rox shown to bind SIN3 (Hurlin et al., 1997; Meroni et al., 1997) . This screening allowed us to identify four new Rox-interactors. In this report we describe the cloning and functional characterization of one of these interactors, a new mammalian bHLHZip protein (see Figure 1a ). Due to its sequence, size, overall similarity and function features we named the gene BigMax (see below).
From the two-hybrid screening, we recovered four clones corresponding to two independent and overlapping BigMax cDNAs (clones 630, 640, 692 and 694, see Figure 1a ). These cDNAs represent the human homolog of murine transcription factor like protein 4 (TCFL4) (Bjerknes and Cheng, 1996) . TCFL4 was cloned from the mouse 17q21 syntenic region where BRCA1 was mapped (Friedman et al., 1994 (Friedman et al., , 1995 . However, these clones lack 162 bp of exon 1 and constitute an alternatively spliced form of the human TCFL4 (isoform BigMax-b, see Figure 1d ). A human clone corresponding to complete murine TCFL4 was also isolated through a database search (isoform BigMax-g, see Figure 1d ) (IMAGE clone 488171). Moreover, a third isoform lacking exon 3 and 162 bp in exon 1 (isoform BigMax-a, see Figure 1d ) was identi®ed in dbEST (IMAGE clones 488652 and 502642) . Nested PCR analysis on cDNA libraries (serum starved WI-38 cells, fetal brain, HeLa and keratinocyte cells) excluded the possibility that the two newly identi®ed splice forms resulted from cloning artifacts. During the preparation of this manuscript, BigMax-b was independently isolated and named Mlx by Donald E Ayer and collaborators in a screen for new Mad1 interactors (Billin et al., 1999) . For the sake of clarity and to avoid confusion, we decided to adopt their nomenclature and name the BigMax-a, -b and -g isoforms, Mlx-a, -b and -g, respectively.
The entire Mlx gene spans approximately 7 kb and is contained in a fully sequenced cosmid (GenBank accession number U34879, (Zhao et al., 1996) ). It consists of eight exons which can be alternatively spliced to encode the dierent isoforms (see Figure  1a,d) . Interestingly, the two shorter isoforms (-a andb) use a cryptic AGgcaagc donor site in exon 1A.
We sequenced the three alternative Mlx-a, -b and -g isoforms and deposited them in GenBank (accession numbers AF213666, AF213667 and AF213668, respectively). The putative initiation codon properly ful®lls Kozak's criteria (Kozak, 1984) , but no in frame 5'UTR STOP codon was identi®ed in any of the six independent clones we isolated. We also cloned and sequenced the murine Mlx alternatively spliced forms to con®rm their existence in rodents (mMlx-a, -b andg, GenBank accession numbers AF213670, AF213671 and AF213672, respectively).
The three human isoforms encode polypeptides of 214, 244 and 298 residues, respectively. They share a common carboxyterminal region and a centrally positioned bHLHZip domain. An alignment of the sequence of human Max and Mlx-a is presented in Figure 1a . Like Mlx, the Max gene can be alternatively spliced and encode Max1, Max2, DMax and dMax. Max1 is 151 residues long, Max2 contains a nine amino-acid insertion before the basic domain, DMax encodes an isoform truncated after the Leucine Zipper and dMax codes for a Max isoform lacking the basic and the ®rst Helix regions (Blackwood and Eisenman, 1991; FitzGerald et al., 1999; Makela et al., 1992; Vastrik et al., 1993) .
Homology searches in dbEST revealed a related gene in Drosophila (BDGP/HHMI EST Project clones GM14426 and LD05447). The full-length sequence of this gene, which we named dMlx, is deposited in GenBank (accession number AF213669). PCR-based cDNA cloning failed to reveal dierent isoforms in embryonic, ovarian and disc¯y libraries (Figure 1b) . The homology is striking in the bHLHZip region (63% identity) and the carboxyterminal tail. The mammalian and insect proteins are 45% identical and 57% similar.
Mlx expression analysis
We analysed the expression pattern of the Mlx gene. It was ®rst assessed by probing multiple adult tissue Northern blots. We detected three dierent mRNA species, approximately 1.4, 2.4 and 3.3 kb in size. All three species are expressed ubiquitously (see Figure  2a) .
Similarly, no speci®c cell lineage expression of Mlx was detected in the analysis of E9.5 through E14.5 mouse embryos. These results are similar to those obtained on the expression of the other members of the Myc/Max/Mad superfamily (Ayer et al., 1993; Hurlin et al., 1995a Hurlin et al., ,b, 1997 Larsson et al., 1994; Meroni et al., 1997; Queva et al., 1998; Zervos et al., 1993) . The overlapping expression of Mlx and Rox in the same tissues and at the same developmental stages is consistent with the possible involvement of Mlx in regulating Rox function (see below).
Although Mlx is ubiquitously expressed, wholemount RNA in situ hybridization experiments, at E9.5 and E10.5, show stronger expression of Mlx in the ventral portion of the central nervous system (Figure 3a,b) . Parallel in situ hybridization of E12.5 sagittal sections shows a prevalent expression in this tissue ( Figure 3c lateral and e medial). Further magni®cation highlights stronger expression in the dorsal root ganglia and in the segmental bronchi epithelia of the developing lung (Figure 3f ). Interestingly, this high expression is not maintained in the surrounding parenchynma. Later in development, high levels of Mlx expression are restricted to the villi of the gut as shown in transversal sections of E14.5 embryos (Figure 3d ). Dierent authors showed that the steady state mRNA levels of c-Myc, L-Myc, N-Myc, Mad1, Mxi1, Mad3, Mad4 and Rox(Mnt) are tightly regulated through cell cycle and dierentiation phases (Armelin et al., 1984; Ayer et al., 1993; Campisi et al., 1984; Kelly et al., 1983; Meroni et al., 1997; Queva et al., 1998) . These observations prompted us to investigate Mlx expression pro®le in synchronized cells. Normal quiescent human lung ®broblasts (WI-38) were obtained by serum starvation for 3 days. The cells were then stimulated to reenter the cell cycle by the addition of 20% fetal bovine serum. Total RNA samples were collected at de®ned times after serum addition and the expression of the three isoforms of Mlx were monitored by Northern blot analysis. Under these conditions, the cells started to synthesize DNA about 12 h after serum addition and after 24 h most of the cells had entered the S phase. Correct synchronization was assessed by hybridization with the S phase speci®c Cyclin A (Figure 2b , bottom lane). Dierent Mlx probes were used to detect either the -g isoform alone, or the b and g isoforms, or the a, b and g isoforms together. These probes are depicted in Figure 1d . They span the last 162 bp of exon 1B, exon 3 and exons 7 ± 8, respectively. Interestingly, the Mlx isoforms b and g mRNA steady state level peaks in S phase (see Figure  2b) . In this regard Mlx shows a unique expression pro®le among the Myc/Max/Mad/Rox family members.
To test whether Mlx isoforms are tissue speci®c, a qualitative study of the presence or absence of the three Mlx isoforms was performed by PCR on the Express-Check panel of 62 tissue-speci®c cDNA libraries (ATCC). We found the three Mlx-a, -b and -g isoforms throughout the panel (data not shown). These data show that Mlx isoforms, like the Max isoforms, are not tissue speci®c. The semi-quantitative PCR conditions used in these experiments allowed us to conclude that in a large number of tissues, Mlx-a and -g are more abundant than the rarer Mlx-b, whereas this ratio is inverted in favor of isoform b in the basal ganglia, liver, placenta and pancreatic islets (data not shown). These results demonstrate that while the isoforms are not tissue speci®c, their ratio probably is, as previously shown for some of the Max protein isoforms (Makela et al., 1992) .
Mlx homodimerizes and heterodimerizes with Rox
We tested whether Mlx is able to interact with members of the bHLHZip family using interactionmating and in vitro co-immunoprecipitation approaches.
To investigate Mlx binding speci®city, we took advantage of the interaction-mating technology (Reymond and Brent, 1995) . Mlx and panels of informative bHLHZip proteins were expressed as fusion proteins with either the LexA-DNA binding domain (bait) or the B42 acidic moiety (prey). A representative mating assay is shown in Figure 4a . Our results con®rmed that Mlx was not interacting with Max, Mxi1, and Mad3, but was heterodimerizing with Mad1 (Billin et al., 1999) . This result, however, was not con®rmed by in vitro co-immunoprecipitation (see below). Moreover, we found no interaction with c-Myc, USF and mi. Substantiating the eciency of the two-hybrid screen we con®rm the ability of Mlx to heterodimerize with Rox in interaction mating assays. Interestingly and contrary to previous beliefs the interaction mating experiments showed also that Mlx was readily homodimerizing (see Figure 4a) .
To determine which regions of Rox and Mlx are responsible for heterodimerization and homodimerization, we created Rox deletion mutants and Mlx-b mutants: (i) LexA-Rox 60 ± 582 lacks the SID; (ii) LexA-Rox 196 ± 582 and LexA-Rox 206 ± 582 lack the SID and the P/Q rich domain; (iii) LexA-Rox 1 ± 300 lacks the carboxyterminal portion of the protein (Cterm); (iv) LexA-Rox 1 ± 198 lacks the bHLHZip domain and the C-term; (v) LexA-Rox 1 ± 120 lacks the bHLHZip domain, the C-term and part of the P/Q rich region; (vi) B42-Mlx-R87K mimicks the basic region dominant negative mutant Oak-Ridge of the microphhtalmia gene (Hemesath et al., 1994) ; (vii) B42-Mlx-I91P/Y95P/L98P disrupts the ®rst Helix and (viii) B42-Mlx-L154P and B42-Mlx-L147P/L154P change one and two conserved leucine residues of the Leucine Zipper domain, respectively.
The ability of Rox deletion mutants and of the Mlxb mutants to retain homodimerization and heterodimerization was tested by interaction-mating. The bHLHZip domain of Rox is essential for interaction with Mlx, as LexA-Rox 206 ± 300 is able to interact with B42-Mlx (see Figure 4b) . It is important to note that the Rox-Mlx interaction is detectable only in yeast with Rox deletion mutants that lack the SID. This domain interacts with ySIN3 and masks the activation of the two-hybrid reporter genes (Meroni et al., 1997) . The disruption of the Mlx ®rst Helix or its Leucine Zipper domain decreases or abolishes its capability to homodimerize and heterodimerize with Rox, while modi®cations of its basic region had no eect (see Figure 4c ). These results con®rm the involvement of the ®rst Helix and Leucine Zipper regions in the dimerization of the bHLHZip family members.
To provide independent evidence for Mlx binding speci®city, we performed co-immunoprecipitation experiments with bHLHZip family members. In vitro translated (IVT) and labeled HA-tagged c-Myc, Max, Mlx, Mad1, Mxi1, Mad3, Mad4 or Rox and FLAGtagged Mlx were mixed and co-immunoprecipitated in low stringency conditions using anti-Mlx, anti-FLAG or anti-HA antibody. The bound and recovered proteins were separated on SDS ± PAGE gels. The results con®rm the interaction-mating assays data made exception of Mad1, i.e. the ability of Mlx to homodimerize and heterodimerize with Rox (data not shown).
We con®rmed Mlx homodimerization and Rox and Mlx interaction in vivo. Cos-7 cells were transiently cotransfected with HA-Rox or FL-Mlx-a and HA-Mlx-a. Cell lysates were immunoprecipitated with anti-HA or anti-FLAG monoclonal antibodies ( Figure 4d ) and speci®c sera raised against Rox or Mlx (Figure 4e ). The bound and recovered proteins were separated on gel and subjected to immunoblot analysis. In Figure 4d , FL-Mlx-a and HA-Mlx-a were recovered in the anti-HA and anti-FLAG immunoprecipitate respectively (lanes 4 and 2), but not in the controls (lanes 3 and 1) substantiating the ability of Mlx to homodimerize. In Figure 4e , correct expression of the transfected proteins was assessed by immunoprecipitation with a commercially available anti-HA antibody (see Figure 4d The results of these in vivo and in vitro coimmunoprecipitations and interaction-mating experiments suggest that Mlx is not using Max as a partner, unlike any other member of the Myc/Max/Mad family. Moreover, like Max, Mlx is homodimerizing and heterodimerizing with diverse members of the bHLHZip family, Rox (this study), Mad1, and Mad4, the interactions with the Mads however were not con®rmed in vivo (Billinet al., 1999) .
Mlx:Mlx and Mlx:Rox dimers bind DNA Max:Max and Max:bHLHZip heterocomplexes bind to E-box containing sequences as reported in the literature (Ayer et al., 1993; Blackwood and Eisenman, 1991; Hurlin et al., 1995b Hurlin et al., , 1997 Meroni et al., 1997; Zervos et al., 1993) . We tested the ability of both Mlx : Mlx and Mlx : Rox dimers to bind to CACGTGcontaining DNA sequences by electrophoretic mobility shift assays (EMSA). Figure 5a shows that a reticulocyte lysate containing IVT HA-Mlx-a or IVT HA-Mlx-g are able to speci®cally bind a labeled oligonucleotide containing the CACGTG E-box sequence (lanes 1 ± 5, 8, 11, 13, 14 and 26) . This protein-DNA complex can be supershifted in the presence of anti-Mlx serum, but not in the presence of preimmune serum or anti-Max antibodies (lanes 9 and 10, respectively and data not shown), or it can be partially supershifted and mostly abolished in the presence of anti-HA antibody (lanes 6 and 15). Consistent with the presence of Mlx in the DNA-protein complex, we observe that the bandshift produced by expression of Mlx-a migrates faster than the bandshift produced by expression of the longer isoform-g (compare lanes 1 and 2). Further analysis demonstrates that Mlx-a:Mlx-g heterocomplexes also bind DNA (lane 7, short exposure). Similarly, the Mlx-b isoform is able to bind CACGTG DNA sequences (data not shown). Alternative splice forms may induce subtle dierences in DNA binding as in the case of Max1 versus Max2 (Prochownik and VanAntwerp, 1993) , but no obvious changes in E-box binding were observed with Mlx-a, -b and -g. These results con®rm the ability of Mlx to readily homodimerize and bind DNA even at low concentration. In this regard Mlx is similar to Max, as Max was the only member of this transcription factors family shown to homodimerize and bind DNA in vitro at low concentration (Ayer et al., 1993; Berberich and Cole, 1992; Hurlin et al., 1995b Hurlin et al., , 1997 Zervos et al., 1993; Zhang et al., 1997a) .
Competition experiments revealed that the Mlxg:Mlx-g complexes were also able to recognize the non-canonical CACGCG DNA sequence, although poorly, but not the Myc:Max canonical site CATGTG or the non-canonical sites CACGAG and CATGCG (see Figure 5b ) (Blackwell et al., 1993) . These data suggest that Mlx:Rox complexes would not only be able to regulate CACGTG but also CACGCG operons, with Mlx binding to the CAC and Rox binding to the GYG half site preferentially.
Reticulocytes expressing both HA-Mlx-g and FLRox show three dierent speci®c DNA-protein complexes: a fast migrating complex and two slower complexes that almost comigrate (see Figure 5a) . Similar results were obtained with the other two Mlx isoforms (data not shown). The faster migrating complex was partially disrupted and partially supershifted in the presence of anti-HA antibody, but no eects were observed in the presence of anti-FLAG antibody (lanes 16 ± 18 and 23 ± 25). These results indicate that the faster migrating complex contains Mlx:Mlx dimers. Besides, the MLR complex (see Figure 5 legend) was disrupted and supershifted in the presence of anti-HA and anti-FLAG antibody, respectively, showing that it contains Mlx:Rox heterodimers (lanes 16 ± 18 and 23 ± 25). Finally, the MAR complex (see Figure 5 legend) was supershifted in the presence of anti-FLAG antibody, but remained unaltered in the presence of anti-HA antibody, showing that this complex contains Max:Rox heterodimers (lanes 16 ± 18 and 23 ± 25). This was con®rmed by the observation that an identical MAR complex can be observed in assays containing reticulocyte expressing only FL-Rox (lanes 19 ± 22). As previously published, the reticulocyte lysate provides enough Max to allow the formation of Max/Rox complexes (Meroni et al., 1997; LoÂ Nigro et al., 1998) . We observed that the two slow migrating bandshifts produced by the expression of Mlx, together with the last 523 residues of Rox, are smaller than the one produced by the expression of Mlx and Rox full-length complexes (compare lanes 17 and 24, 18 and 23, 16 and 25). On the other hand, no dierences in the size of the faster migrating bandshift are observed (compare lanes 17 and 24, 18 and 23). These data are consistent with the presence of Rox in both of the slow migrating complexes and with its Oncogene Mlx, a Max-like protein G Meroni et al absence from the faster migrating DNA-protein complex.
To summarize, the results presented in Figure 5a , con®rm the ability of Mlx to both homodimerize and heterodimerize, and indicate that these complexes are able to bind E-box DNA sequences. Moreover, they demonstrate that Mlx, like Max, is able to bind DNA as a homodimer, a feature unshared by c-Myc, L-Myc, N-Myc, Mad1, Mxi1, Mad3, Mad4 and Rox/Mnt at non-extreme concentration levels. The ability of Mlx to homodimerize and bind DNA was not detected in previously published reports (Billin et al., 1999) . To explain this discrepancy, we can speculate that Mlx post-traductional modi®cations essential for homodimerization are ful®lled by reticulocyte lysates expressed Mlx. 
Like Max, Mlx does not affect transcription on its own
We wanted next to understand what was the in¯uence of Mlx on transcription. Previous works have demonstrated that Myc activates or de-represses transcription from a reporter construct with proximal E-box binding sites (Amati et al., 1992; Gu et al., 1993; Kretzner et al., 1992) , while Mad1, Mxi1, Mad3, Mad4 repress from the same site (Ayer et al., 1993; Gupta et al., 1998; Hurlin et al., 1995b) . We addressed the potential transcriptional activity of the three Mlx isoforms by transiently expressing the genes in HEK293 cells, where no Mlx protein is detectable (Billin et al., 1999) , together with a luciferase reporter construct containing four reiterations of the CACGTG binding site upstream of a thymidine kinase minimal promoter. Transfections of Mlx-a or -g resulted in a moderate decrease of the luciferase activity, while transfection with the b isoform had no eect (see Figure 5c , lanes 1 ± 4). The repression of the background level of transcription is consistent with the binding of transcriptionally inert Mlx homodimers to CACGTG. Max was shown to repress transcription presumably with a similar mechanism (Kretzner et al., 1992) .
In agreement with published reports, overexpression of Rox(Mnt) causes an approximate 5 ± 6-fold decrease in luciferase activity compared with control transfection (lanes 5 ± 6) (Hurlin et al., 1997; Meroni et al., 1997) . The co-expression of any Mlx isoform was not enhancing this repression activity (lanes 5 ± 9), suggesting that Mlx:Rox complexes have similar properties than Max:Rox dimers. However synergy upon transcription activity was observed when Mlx was cotransfected with Mir, a previously unidenti®ed bHLHZip protein (G Merla and A Reymond, in preparation).
Mlx isoforms show different subcellular distribution
We determined the Mlx isoforms subcellular localization by indirect immuno¯uorescence. HeLa and Cos-7 cells were transiently transfected with a plasmid expressing each of the HA-tagged Mlx isoforms. The results are presented in Figure 6a and summarized in Figure 6b . The two shorter isoforms, Mlx-a and -b, are predominantly cytoplasmic and only partially nuclear, while the Mlx-g isoform shows a predominantly nuclear localization. The longer isoform diers from both of the two shorter isoforms by the presence of exon 1B, which is 54 residues longer than exon 1A (see Figure 1a ,b,c). Two sequences GRAGRARARR-GAGRR and PACAKV, resembling a bipartite nuclear localization signal (NLS) and a portion of the c-Myc NLS (PAAKRVKLD), are present in this exon (reviewed in Nigg, 1997) . To further assess the importance of these sequences in addressing Mlx-g to the nucleus, we generated mutant constructs and analysed their subcellular localization. Any tested double amino-acids substitution of consecutively positively charged residues of the GRARARARRGAGRR sequence in¯uences negatively, but not dramatically, the nuclear localization of the Mlx-g isoform (see Figure 6b) . Interestingly, the mutation K68T/V69G, which aects the region with low similarity to the cMyc NLS, alters the subcellular localization of Mlx-g. These observations con®rm that the basic residue-rich exon 1B encoded amino acids are necessary for the predominantly nuclear localization of Mlx-g.
To test if this basic residue-rich region is sucient to localize Mlx in the nucleus, we generated fusions between the avian pyruvate kinase, a strictly cytoplasmic protein, and (i) Mlx-g residues 14 to 93 and (ii) Mlx-g residues 14 to 147. These peptides contain both the above-described NLS-like sequences. Furthermore, the second peptide also includes the basic region of the bHLHZip domain. The fusion proteins produced localize in the cytoplasm (data not shown), whereas the control fusion protein, between the SV40 T NLS and the pyruvate kinase, results in the relocalization of this kinase into the nucleus. These and the above described results suggest that the exon 1B basic region plays a role in nuclear localization and that it does not contain a bona ®de NLS. It is conceivable that Mlx-g translocates into the nucleus after association with other proteins. Either these Mlx interactors possess their proper NLS and Mlx exon 1B increases the anity for the protein partner, or the formed dimer acts with the participation of exon 1B to create a de novo NLS.
We also checked the presence of a piggy-back mechanism of nuclear import by co-transfecting the predominantly cytoplasmic EGFP-tagged Mlx-a isoform together with the nuclear HA-tagged Mlx-g isoform in HeLa and Cos-7 cells. We reasoned that the ability of Mlx to homodimerize might induce relocalization of one of the isoforms upon presence of the other. Almost two thirds of the cells transfected with Mlx-a show a predominantly cytoplasmic distribution of the protein (35 and 40% of nuclear stained Cos-7 and HeLa cells, respectively). Upon co-transfection with the Mlx-g isoform, the Mlx-a isoform is relocated preferentially to the nucleus (72 and 90% of nuclear stained Cos-7 and HeLa cells, respectively) substantiating the hypothesis that a piggy-back mechanism is involved in the regulation of the subcellular distribution of the Mlx isoforms. The slight dierences in the subcellular localization of the three Mlx isoforms can account for their dierences in transcription assays. Moreover, our data indicate that the ability of Mlx to homodimerize induces relocalization of some isoform upon presence of the other. Furthermore, the basic residue-rich exon 1B is necessary, but not sucient, for the predominantly nuclear localization of Mlx-g.
Discussion
In this paper, we described the isolation in a screen for new Rox interactors of the bHLHZip protein, Mlx. It resembles Max in its features and function. This protein was independently identi®ed in a screen for new Mad1 interactors (Billin et al., 1999) . Mlx does not interact with the Max protein unlike the already known members of the Myc/Max/Mad/Rox family, while it heterodimerizes with Rox (this study), Mad1, Mad4 (Billin et al., 1999) and with two previously unidenti®ed bHLHZip proteins (S Cairo, G Merla, A Reymond, manuscript in preparation). We found that, like Max, Mlx binds to E-box DNA as a homodimer. We propose that Mlx might be positioned at the center of a novel transcription-factor network parallel to the Max regulatory pathway.
The ratio between Max partners (c-Myc, L-Myc, NMyc, Mad1, Mxi1, Mad3, Mad4 and Rox/Mnt) plays a major role in the cell decision to divide, to dierentiate or to apoptose (reviewed in Dang, 1999; Eilers, 1999) . The stable Max protein binds to the labile Myc proteins to promote cell proliferation. This function is mediated by the activation and/or derepression of speci®c genes crucial to cell proliferation. These speci®c targets include a-prothymosin, eIF4E, cad, ornithine decarboxylase, CDC25, the DEAD box gene MrDb, ISGF3 g, IRP2, QNR-71, RCC1, rcl, cyclin D2, ECA39, and TERT (reviewed in Cole and McMahon, 1999; Dang, 1999; Peters and Taparowsky, 1998) . This Myc transactivation and/or derepression is accompanied by loss of expression of some genes, which include H-ferritin, CIP1/WAF1, gas1, cyclinD1, gadd34, gadd45, gadd153 and c-Myc itself (reviewed in Claassen and Hann, 1999) . Repression is generated, either through initiator elements in the genes basal promoter (Li et al., 1994) , or indirectly by sequestration (Peukert et al., 1997; Shrivastava et al., 1993) . The dierent Myc:Max responsive genes were generally identi®ed through expression of exogenous protein and hence critical physiological targets remain unclear. For example, c-Myc null cells misregulate cad and gadd45, but no other proposed targets .
On the other hand, Max association to Mad1, Mxi1, Mad3, Mad4 or to Rox/Mnt was shown to block MycRas transformation (Hurlin et al., 1995b (Hurlin et al., , 1997 Schreiber Agus et al., 1995) . It seems likely that this eect is mediated through repression of the genes normally transactivated by the Myc:Max complex. The Mad:Max and Rox:Max complexes were shown to bind E-box DNA sequences and the mSIN3 corepressors, and to repress transcription, at least in part, by tethering histone deacetylases containing complexes to the DNA (Alland et al., 1997; Ayer et al., 1993; Hassig et al., 1997; Heinzel et al., 1997; Hurlin et al., 1995b Hurlin et al., , 1997 Laherty et al., 1997; Meroni et al., 1997; Nagy et al., 1997; Schreiber Agus et al., 1995; Zhang et al., 1997b) .
What is the function of the Mlx protein with regard to these highly dynamic processes? It is apparent that Mlx can substitute Max to allow the Mad1, Mad4 and Rox proteins to bind DNA. This might either promote a further level of control over the Max network by regulation of the same target genes, or it may be the tip of the iceberg of a new network of genes required for progression through S phase and/or dierentiation. Mlx is expressed broadly like Max, c-Myc, L-Myc, NMyc, Mad1, Mxi1, Mad3, Mad4 and Rox/Mnt (Ayer et al., 1993; Hurlin et al., 1995a Hurlin et al., ,b, 1997 Larsson et al., 1994; Meroni et al., 1997; Zervos et al., 1993) , but their respective temporal patterns of expression are extremely dierent. If Max steady state level is constant through the cell cycle , Rox is expressed in G0 in WI-38 cells (Meroni et al., 1997) , while Myc and Mlx expressions peak at the G0-G1 and G1-S transitions, respectively, in these cells (Meroni et al., 1997) (this work). Finally Mad3, Mxi1, Mad4 and Mad1 are sequentially induced during dierentiation (Queva et al., 1998) . Hence Mlx might be important in the sequence of events leading to commitment to the cell cycle and the beginning of S phase. First, the repression program is lifted at target sites of Max:Rox complexes, when expression of Myc favors the formation of Myc:Max dimers. Then unbound Rox might be recruited by Mlx to control the expression of other genes and/or to prevent undestroyed Rox from antagonizing Myc function and cell proliferation.
On the other hand studies of E-box DNA binding complexes have revealed that Mad1:Max heterodimers were unlikely to be essential or determining for myeloid dierentiation (Ryan and Birnie, 1997) . As Mlx interacts with Mad1 and Mad4 (Billin et al., 1999) , which are expressed late in the dierentiation process (Queva et al., 1998) , we can hypothesize that dierentiation of HL60 cells is dependent of Mad1:Mlx heterocomplexes. Future studies will con®rm or in®rm this possibility. However, if this is the case Mlx might be important for dierentiation of speci®c cell types.
It is even possible that Mlx exert a partially redundant function with Max in speci®c cell types and/or cellular dierentiation stages. For example, the rat nerve growth factor-responsive PC12 cells express a mutant form of Max unable to dimerize. They therefore divide and apoptose through Max/Myc independent pathways (Hopewell and Zi, 1995) . Interestingly enough these particular cells express the rat homolog of Mlx (clone RPCCD51, accession H32587, ), suggesting that PC12 cells are dividing through a Mlx pathway. We are currently investigating this possibility.
Another question concerns the functional role of the Mlx:Mlx homodimers. Like the Max protein, but unlike any other members of the Myc network, Mlx readily homodimerizes at low concentration and binds CACGTG binding sites in EMSA. It has been proposed that the Max:Max homodimers are`transient states' that exist to accelerate transition from the Myc:Max to the Mad:Max complexes . We can postulate a similar role for the Mlx:Mlx complexes, as we have identi®ed additional Mlxcontaining heterodimers (S Cairo, G Merla, A Reymond, in preparation). However, we cannot exclude that occupation of the target genes by the Mlx:Mlx or the Max:Max homodimers has no physiological function.
Finally, we can speculate a possible role of Mlx in tumorigenesis. Myc family members are activated in a large number of neoplasias (reviewed in Nesbit et al., 1999) . Consistently, its antagonist, Mxi1, was shown to be a tumor suppressor both in human and rodents (Eagle et al., 1995; Li et al., 1999; Schreiber Agus et al., 1998) . Tantalizingly enough, Mlx maps to the gene rich region of 17q21, centromeric to the BRCA1 gene (Friedman et al., 1994 (Friedman et al., , 1995 . This chromosomal region frequently presents loss of heterozygosity in ovarian (75%), breast (50%) and prostate (40%) cancers (reviewed in Aita et al., 1999) . BRCA1 is implicated in familial, but rarely in sporadic cases of breast and ovarian cancer (Futreal et al., 1994; Miki, 1994) . Moreover, sporadic ovarian cancer tumors with allelic deletion of 17q21 region but no BRCA1 mutation were isolated. These ®ndings led to the hypothesis that at least one other tumor suppressor gene, in addition to BRCA1, maps to 17q21 (Vogelstein and Kinzler, 1994) . Interestingly, a 400 kb common deletion unit centromeric to BRCA1 and containing the Mlx gene was identi®ed in sporadic ovarian cancer (Tangir et al., 1996) . We are currently performing mutation analysis to evaluate if the Mlx gene is mutated in these types of tumors.
In conclusion, we have extended the known dimerization partners of Mlx, a new bHLHZip protein, by demonstrating its ability to bind Rox and to homodimerize. Mlx, like Max, is positioned at the center of a network of transcription factors. The importance of this network is emphasized by its conservation through evolution, as we cloned both the Mlx and the Rox fruit¯y homologs (see the Results section and E Zanaria and G Meroni, unpublished data). Other members of the Myc/Max/Mad bHLHZip family were previously identi®ed in invertebrates and their biological and biochemical properties were shown to be identical to that of their vertebrate counterparts (Gallant et al., 1996; Schreiber Agus et al., 1997; Walker et al., 1992; Yuan et al., 1998) .
Materials and methods
Yeast two-hybrid screen and cloning of Mlx
The yeast two-hybrid screen was performed as described in (Zervos et al., 1993) . Brie¯y, 1.2 Mio clones of a HeLa cDNA JG4-5 library were screened for interaction with the last 523 residues of the Rox protein Meroni et al., 1997) . The prey plasmids express the cDNA directionally fused to the B42 activation domain, the SV40 T NLS and a HA tag under the control of the GAL1. Interaction-mating techniques were used to recon®rm interaction after isolation of two-hybrid positive clone (Reymond and Brent, 1995) .
The Mlx-b and -g point mutants used in this manuscript were generated using the Quick-Change mutagenesis kit (Stratagene) and appropriate oligonucleotides.
Co-immunoprecipitation and antibody production
In vitro and in vivo co-immunoprecipitations have been previously described (Meroni et al., 1997; Reymond and Brent, 1995) . The last 88 residues of Mlx fused to GST were expressed in bacteria and puri®ed as published (Reymond and Brent, 1995) . Two rabbits were injected intramuscularly at monthly intervals to generate Mlx antisera.
Bandshift assays
The binding reaction was achieved as described in (Meroni et al., 1997) using 1 ng of end-labeled probe (5'-GGAAGCA-GACCACGTGGTCTGCTTCC-3'). When speci®ed, unlabeled probe or speci®c competitors were added at the same time as the labeled probe. Speci®c sequences of competitors are described in detail in (Meroni et al., 1997) . For supershift experiments, 1 mg of puri®ed anti-FLAG M2 antibody (Eastman Kodak), 1 mg of puri®ed anti-HA 12CA5 (Boehringer Mannheim), 5 mg of puri®ed anti-Max C-17, 5 mg of puri®ed anti-Max C-17 or C-124 (Santa Cruz Biotechnology) or 5 mg of immune or preimmune anti-Mlx antisera were added to the reaction mix after protein-DNA complex formation.
Indirect immunofluorescence, transfection and transactivation experiments
Indirect immunostaining was performed on paraformaldehyde-®xed cells 3 days posttransfection as explained in (Reymond et al., 1999) . 12CA5 anti-HA mAb or anti-Mlx anti-sera were used. HEK293 and Hela cells were transfected by calcium phosphate and COS-7 with lipofectamine (Gibco BRL).
For the transactivation experiments 1.5610 5 cells/35 mm plate were transfected with 1 mg of pTK81 4x[CACGTG]-luciferase reporter (Meroni et al., 1997) , 1 mg of the expression vector(s) (pCDNA3 modi®ed to include an HATag, Invitrogen) and 100 ng of pCH110 (SV40 promoter driven b-Galactosidase; Clontech) to monitor transfection eciency. Luciferase and b-Galactosidase were assayed according to the manufacturer's instructions (Promega) 72 h post-transfection. Transactivation assays were performed in triplicate with and without TSA and repeated at least ®ve times.
Expression studies
Human multiple tissues Northern blots (Clontech) were hybridized with clone 692 following the manufacturer's recommendation. Mouse embryo sections were hybridized with 35 S-UTP-labeled IMAGE clone 520937 riboprobes as described (Reymond et al., 1999) . Specimens were viewed and photographed using Hoechst epi¯uorescence optics combined with dark®eld illumination provided by a red light source. Whole-mount in situ hybridization of mouse embryos was performed as published in (Riddle et al., 1993) using digoxigenin-labeled IMAGE clone 520937 riboprobes. WI-38 human embryo lung ®broblasts were cultured at early passages in DMEM/10% FCS and arrested for 3 days in media with 5% BCS. They were stimulated to re-enter the cell cycle by addition of 20% FCS. RNA was isolated from synchronized cells as described (Chomczynsky and Sacchi, 1987) .
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